){kind=logo}
Represented PharmaCyte Biotech, Inc., a clinical-stage international biotechnology company providing cell and gene therapy solutions, in an “at the market” banking agreement with Chardan Capital Markets, LLC of up to $50 million.
-
合伙人 -
副主席兼纽约办公室管理合伙人；资本市场及公司业务部联席主席；亚洲业务部主席”; 纽约，北京 -
Assistant Deputy Chair, Capital Markets and Corporate